Cargando...
Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating non‐muscle‐invasive bladder cancer
BACKGROUND: Despite local therapies, commonly transurethral resection (TUR) followed by adjuvant treatments, non‐muscle‐invasive bladder cancer (NMIBC) has a high rate of recurrence and progression. Intravesical Bacillus Calmette‐Guérin (BCG) has been shown to reduce recurrence and progression in pe...
Guardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2017
|
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464648/ https://ncbi.nlm.nih.gov/pubmed/28268259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012112.pub2 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|